orlistat and Leukemia--T-Cell

orlistat has been researched along with Leukemia--T-Cell* in 1 studies

Other Studies

1 other study(ies) available for orlistat and Leukemia--T-Cell

Article	Year
Fatty acid synthase inhibitor orlistat impairs cell growth and down-regulates PD-L1 expression of a human T-cell leukemia line. Journal of chemotherapy (Florence, Italy), 2020, Volume: 32, Issue:1 Fatty Acid Synthase (FASN) is responsible for the Topics: B7-H1 Antigen; Cell Proliferation; Down-Regulation; Enzyme Inhibitors; Fatty Acid Synthase, Type I; Humans; Jurkat Cells; Leukemia, T-Cell; Orlistat	2020

Article

Year

Fatty acid synthase inhibitor orlistat impairs cell growth and down-regulates PD-L1 expression of a human T-cell leukemia line.

Journal of chemotherapy (Florence, Italy), 2020, Volume: 32, Issue:1

Fatty Acid Synthase (FASN) is responsible for the

Topics: B7-H1 Antigen; Cell Proliferation; Down-Regulation; Enzyme Inhibitors; Fatty Acid Synthase, Type I; Humans; Jurkat Cells; Leukemia, T-Cell; Orlistat

2020